CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · IEX Real-Time Price · USD
0.204
-0.006 (-2.67%)
At close: Apr 17, 2024, 4:00 PM
0.238
+0.034 (16.44%)
Pre-market: Apr 18, 2024, 5:28 AM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $2.17 million as of April 18, 2024. Its market cap has increased by 35.86% in one year.
Market Cap
2.17M
Enterprise Value
1.93M
1-Year Change
35.86%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $71.80M to $2.17M, a decrease of -96.97%. That is a compound annual growth rate of -54.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 2.20M | - |
Apr 16, 2024 | 2.20M | -15.38% |
Apr 15, 2024 | 2.60M | - |
Apr 12, 2024 | 2.60M | - |
Apr 11, 2024 | 2.60M | 4.00% |
Apr 10, 2024 | 2.50M | 4.17% |
Apr 9, 2024 | 2.40M | - |
Apr 8, 2024 | 2.40M | -14.29% |
Apr 5, 2024 | 2.80M | -6.67% |
Apr 4, 2024 | 3.00M | -3.23% |
Apr 3, 2024 | 3.10M | -6.06% |
Apr 2, 2024 | 3.30M | -13.16% |
Apr 1, 2024 | 3.80M | 72.73% |
Mar 28, 2024 | 2.20M | -4.35% |
Mar 27, 2024 | 2.30M | - |
Mar 26, 2024 | 2.30M | - |
Mar 25, 2024 | 2.30M | - |
Mar 22, 2024 | 2.30M | 4.55% |
Mar 21, 2024 | 2.20M | - |
Mar 20, 2024 | 2.20M | - |
Mar 19, 2024 | 2.20M | -4.35% |
Mar 18, 2024 | 2.30M | 4.55% |
Mar 15, 2024 | 2.20M | -12.00% |
Mar 14, 2024 | 2.50M | 4.17% |
Mar 13, 2024 | 2.40M | -11.11% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SCWorx | 2.54M |
FOXO Technologies | 2.41M |
NovaBay Pharmaceuticals | 2.39M |
Bio-Path Holdings | 2.30M |
Nuwellis | 2.28M |
Cyclacel Pharmaceuticals | 2.20M |
ThermoGenesis Holdings | 2.20M |
Salarius Pharmaceuticals | 2.16M |